Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ALMR
ALMR logo

ALMR Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
24.000
Open
22.710
VWAP
22.66
Vol
2.16M
Mkt Cap
--
Low
21.860
Amount
48.84M
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Events Timeline

(ET)
2026-04-17
12:40:00
New
Alamar Biosciences Prices 11.25M Shares at $17.00
select
2026-04-17
11:30:00
New
Alamar Biosciences Prices 11.25M Shares at $17.00
select
2026-04-17
06:40:00
Deal Size Increased to 11.25M Shares
select

News

renaissancecapital
8.5
09:10 AMrenaissancecapital
PinnedAlamar Biosciences Plans $150 Million IPO to Advance Protein Biomarker Detection
  • IPO Fundraising Goal: Alamar Biosciences announced plans to raise $150 million by offering 9.4 million shares at a price range of $15 to $17, aimed at supporting the development and commercialization of its protein biomarker detection platform.
  • Technological Edge: The company's proteomics technology enables the detection and analysis of protein biomarkers at very low concentrations in biological samples, combining proprietary instruments, consumables, and software to provide an end-to-end system for measuring multiple low-abundance proteins, enhancing disease detection accuracy.
  • Market Potential: Alamar Biosciences' technology spans a wide range of applications from early-stage discovery to translational research, emphasizing the need for more precise and consistent protein detection in clinical applications to meet the growing healthcare demands.
  • Financial Performance: Founded in 2018, the company reported $74 million in revenue for the 12 months ending December 31, 2025, indicating its rapid growth potential in the biotechnology sector.
seekingalpha
8.5
15:11 PMseekingalpha
Alamar Biosciences Prices Upsized IPO at $17.00
  • Successful IPO Pricing: Alamar Biosciences priced its upsized initial public offering at $17.00 per share for approximately 11.3 million shares, aiming to raise about $191 million in gross proceeds, reflecting strong market demand for its protein detection and analysis technologies.
  • Trading Debut: The company is set to debut on the Nasdaq Global Select under the ticker symbol “ALMR” on Friday, marking a significant milestone in its commercial stage and laying the groundwork for future growth.
  • Underwriter Option: Underwriters will have a 30-day option to purchase an additional ~1.7 million shares at the IPO price, providing the company with added financial flexibility and enhancing its capital structure.
  • Adjusted Fundraising Goals: Earlier this week, Alamar aimed to offer ~9.4 million shares at a targeted price range of $15–$17, potentially raising up to $159 million at the top of the range, demonstrating the company's keen market insight and adaptability.
renaissancecapital
8.5
13:08 PMrenaissancecapital
Alamar Biosciences Raises $191 Million in IPO at High End of Range
  • Significant Fundraising: Alamar Biosciences successfully raised $191 million by offering 11.3 million shares at $17 each, reaching the high end of its $15 to $17 range, indicating strong market demand for its protein biomarker detection platform.
  • Oversubscription Success: The number of shares sold exceeded the original plan of 9.4 million by 20%, reflecting investor confidence in Alamar's proteomics technology, thereby strengthening the company's capital base to support future R&D.
  • Technological Platform Advantage: Alamar's platform integrates proprietary instruments, consumables, and software to detect and analyze low-abundance protein biomarkers in biological samples, applicable across various fields from early-stage discovery to translational research, enhancing precision and consistency in disease detection.
  • Clear Market Positioning: Based in Fremont, CA, the company plans to trade on Nasdaq under the symbol ALMR, and with this fundraising, Alamar aims to further solidify its market position in biomedical research and clinical applications.
Wall Street analysts forecast ALMR stock price to rise
0 Analyst Rating
Wall Street analysts forecast ALMR stock price to rise
0 Buy
0 Hold
0 Sell
Current: 0.000
sliders
Low
Averages
High
Current: 0.000
sliders
Low
Averages
High
No data

No data

Valuation Metrics

The current forward P/E ratio for Alamar Biosciences, Inc. (ALMR.O) is --, compared to its 5-year average forward P/E of --. For a more detailed relative valuation and DCF analysis to assess Alamar Biosciences, Inc.'s fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
Current PE
NaN
Overvalued PE
Undervalued PE

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
Current EV/EBITDA
NaN
Overvalued EV/EBITDA
Undervalued EV/EBITDA

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
Current PS
NaN
Overvalued PS
Undervalued PS

Financials

AI Analysis
Annual
Quarterly

Whales Holding ALMR

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Alamar Biosciences, Inc. (ALMR) stock price today?

The current price of ALMR is 22.11 USD — it has increased 30.06

What is Alamar Biosciences, Inc. (ALMR)'s business?

What is the price predicton of ALMR Stock?

Wall Street analysts forecast ALMR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALMR is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Alamar Biosciences, Inc. (ALMR)'s revenue for the last quarter?

Alamar Biosciences, Inc. revenue for the last quarter amounts to NaN USD, decreased

What is Alamar Biosciences, Inc. (ALMR)'s earnings per share (EPS) for the last quarter?

Alamar Biosciences, Inc.. EPS for the last quarter amounts to USD, decreased

How many employees does Alamar Biosciences, Inc. (ALMR). have?

Alamar Biosciences, Inc. (ALMR) has 0 emplpoyees as of April 17 2026.

What is Alamar Biosciences, Inc. (ALMR) market cap?

Today ALMR has the market capitalization of 0.00 USD.